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The combinatory use of high-intensity focused ultrasound (HIFU) and epirubicin (EPI)-
conjugated polymeric micellar nanoparticles (NC-6300) is thought to be a less invasive
and more efficient method of cancer therapy. To investigate the mechanism underlying
the combination effect, we examined the effect of trigger-pulsed HIFU (TP-HIFU) and
NC-6300 from the perspective of reactive oxygen species (ROS) generation, which is
considered the primary function of sonodynamic therapy (SDT), and changes in drug
characteristics. TP-HIFU is an effective sequence for generating hydroxyl radicals to kill
cancer cells. EPI was susceptible to degradation by TP-HIFU through the production
of hydroxyl radicals. In contrast, EPI degradation of NC-6300 was suppressed by the
hydrophilic shell of the micelles. NC-6300 also exhibited a sonosensitizer function, which
promoted the generation of superoxide anions by TP-HIFU irradiation. The amount
of ROS produced by TP-HIFU reached a level that caused structural changes to the
cellular membrane. In conclusion, drug-conjugated micellar nanoparticles are more
desirable for SDT because of accelerated ROS production and drug protection from
ROS. Furthermore, a combination of NC-6300 and TP-HIFU is useful for minimally
invasive cancer therapy with cooperative effects of HIFU-derived features, antitumor
activity of EPI, and increased ROS generation to cause damage to cancer cells.
Keywords: sonodynamic therapy, high-intensity focused ultrasound, reactive oxygen species, triggered high-
intensity focused ultrasound, drug-conjugated polymeric micelles
INTRODUCTION
The application of ultrasound has greatly improved disease diagnosis and therapeutics in clinical
practice. High-intensity focused ultrasound (HIFU) is an important method that causes a large
temperature increase at the focal region, causing thermal ablation of tissue (Dubinsky et al.,
2008). HIFU is clinically employed for managing prostate cancer, hepatocellular carcinoma, uterine
leiomyomas, and breast tumors (Copelan et al., 2015). Although ablation itself has large effects, the
higher energy is associated with the risk of adverse effects like skin burns and the possibility of
energy absorption in the muscles and bones in the body (Copelan et al., 2015).
Sonodynamic therapy (SDT) is a combination treatment of ultrasound irradiation and
sonosensitizer administration that shows potential as a minimally invasive treatment for
cancer (Lafond et al., 2018). The sonosensitizer originated from the photosensitizer used
for photodynamic therapy and displayed similar functions when combined with ultrasound
instead of light (Umemura et al., 1993; Tachibana et al., 2008). Several sonosensitizers have
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been reported, including the porphyrin complex, rose Bengal,
titanium oxide, gold nanoparticles, and anticancer drugs like
anthracyclines (Costley et al., 2015).
Although the mechanism of SDT is unclear, it is probably
based on the activation of a sonosensitizer via acoustic cavitation
and generation of reactive oxygen species (ROS) (Riesz et al.,
1985). In photodynamic therapy, the trigger for singlet oxygen
generation is the light-based excitation of the photo-sensitizer.
In contrast, SDT is thought to be more complex because
of the non-direct reaction between the sonosensitizer and
ultrasound. Some intermediate steps are related to acoustic
cavitation between the initiation of ultrasound irradiation
and final ROS generation. Acoustic cavitation involves gas
bubbles in the medium generated via ultrasound irradiation.
Inertial cavitation refers to the rapid growth and collapse of
bubbles, and stable cavitation refers to the sustained oscillatory
motion of bubbles (Mitragotri, 2005). A previous study
suggested two major mechanisms of ROS generation via acoustic
cavitation, referred to as “sono-luminescence” and “pyrolysis”
(Misik and Riesz, 2000; Kuroki et al., 2007).
Several ROS are reportedly involved in SDT. Hydroxyl radicals
are well-known ultrasound-related ROS (Misik and Riesz,
2000). The superoxide anion is generated from doxorubicin,
a widely used anticancer agent (Yumita et al., 1989). Singlet
oxygen is generated via SDT and photodynamic therapy
(Canavese et al., 2018).
Numerous challenges exist regarding nanoparticle
preparation via sonosensitizers (Serpe et al., 2012). Some sono-
sensitizers are highly hydrophobic and show a disadvantageous
distribution in the body. To overcome these limitations,
an approach for forming nanoparticles, which are useful
as drug delivery systems and include liposomes, polymers,
and poly(lactic-co-glycolic acid), were reported including
microbubble encapsulation (McEwan et al., 2014; Yan et al., 2016;
Feng et al., 2018; Wang et al., 2018). In addition to improving
the distribution and sono-chemical activity, the existence of
a particle in a liquid promotes the formation of a cavitation
bubble because of its surface roughness (Serpe et al., 2012). As
another related technology, liposome preparations that release
temperature-sensitive drugs following HIFU irradiation are
being examined (Boissenot et al., 2016).
NC-6300 is an EPI-conjugated polyethylene glycol
polyaspartate block copolymer. The conjugates form a micellar
structure in aqueous media and exhibit the unique feature of
pH-dependent drug release. Approximately 80% of EPI was
found to be released within 1 h at pH 3 (Harada et al., 2011). This
drug delivery system carrier has been confirmed to be safe based
on the results of a phase 1 clinical trial (Mukai et al., 2017).
Trigger-pulsed HIFU (TP-HIFU) is a programmed sequence
consisting of two ultrasound waves. One is a high-intensity
short duration pulse and the other is moderate-intensity long
sustaining wave (Yoshizawa et al., 2016; Iwasaki et al., 2018).
TP-HIFU irradiation accelerates the generation of microbubble
clouds and thermal coagulation (Umemura et al., 2013).
We found that the combinatory use of NC-6300 and TP-HIFU
irradiation was much more effective than each single therapy
(Maeda et al., 2017). We also conducted clinical safety tests for
TP-HIFU and NC-6300 in pet dogs and confirmed the superior
safety of this method.
Despite this progress in practical application, the mechanism
of the combination effect and functional significance of the
drug-polymer conjugate is unclear. In this study, we examined
the effect of the combination of TP-HIFU and NC-6300
from the perspective of ROS generation and changes in
drug characteristics.
MATERIALS AND METHODS
Reagents
NC-6300 was obtained from NanoCarrier Co., Ltd. (with material
transfer agreement) and diluted in Dulbecco’s phosphate-
buffered saline (DPBS) to prepare a stock solution (EPI
concentration of 2 mM). EPI, distilled water, superoxide
dismutase, RPMI 1640 medium, and accutase were from
Nacalai Tesque (Kyoto, Japan). DPBS, iron(II) FeSO4, H2O2,
xanthine, and xanthine oxidase were from Fujifilm Wako
Pure Chemical (Osaka, Japan). Fetal bovine serum was from
Gibco (Grand Island, NY, United States). Penicillin-streptomycin
solution was from Sigma (St. Louis, MO, United States).
Hydroxy phenyl fluorescein (HPF) was from Goryo Chemical
(Sapporo, Japan), and Cell Counting Kit-8 (CCK-8) and
WST-1 were from Dojindo Laboratories (Kumamoto, Japan).
The Annexin V fluorescein isothiocyanate (FITC)-propidium
iodide (PI) kit was from Medical and Biological Laboratories
(Nagoya, Japan).
Cell Lines
Human pancreas adenocarcinoma (BxPC-3) cells were obtained
from the American Type Culture Collection (Manassas, VA,
United States) and human peripheral blood promyeloblast
(HL-60) cells were from the Japanese Collection of Research
Bioresources Cell Bank. The cells were cultured in RPMI-1640
medium containing 10% fetal bovine serum and penicillin-
streptomycin at 37◦C and 5% CO2 in an incubator.
HIFU Irradiation
The in vitro HIFU system was constructed as shown in
Figure 1. The transducer was designed using a lead zirconate
titanate ceramic element (resonant frequency 1.09 MHz,
focus distance from transducer 75 mm) (Abe et al., 2014;
Yoshizawa et al., 2016; Maeda et al., 2017). The input
signal was amplified with an amplifier (A300, Electronics
and Innovation, Rochester, NY, United States) through the
transducer, followed by the generation of the sequence by
the function generator (WF1974, NF Corporation, Yokohama,
Japan). The HIFU conditions (trigger sequence and duration
of irradiation) were controlled with original software. The
ultrasound intensity (spatial peak temporal average intensity;
ISPTA, W/cm2) was measured using a needle-type hydrophone
(HPM05, Precision Acoustics, Dorset, United Kingdom). TP-
HIFU is a programmed wave mixture of a short-duration high-
intensity triggering pulse (2000 W/cm2, 0.02 ms) followed by
a heating wave (10–1000 W/cm2). N-HIFU was single heating
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FIGURE 1 | (A) Schematic of the experimental setup. HIFU condition (trigger sequence and duration of irradiation) was controlled using original software. The signal
generated from the function generator was amplified and then output to the transducer. (B) Sequence of TP-HIFU. High-intensity triggering pulse and heating wave
were irradiated repeatedly. (C) Structure of NC-6300.
wave irradiation (100 W/cm2) without the triggering pulse.
The output energy of TP-HIFU at an ultrasound intensity of
100 W/cm2 was 10 W.
All irradiation experiments were conducted in a water bath,
which was filled with degassed circulating water (DEGASi High
Flow, Biotec, Onsala, Sweden). The water temperature and
dissolved oxygen concentration were maintained at 25± 2◦C and
<3 mg/mL, respectively (Figure 1).
The sample container for HIFU irradiation was changed as
was necessary. Because plastic containers are easily deformed by
high temperatures and long-duration irradiation, glass test tubes
were used. For short-duration irradiation, 48- and 96-well plates
were used to process multiple samples in one experiment.
Experiment on Degradation Stability and
Release of EPI
The drug was dissolved in DPBS and irradiated with HIFU. Next,
the drug concentration was measured using high-performance
liquid chromatography as previously described for NC-6300
(Harada et al., 2011), with some modifications required for the
laboratory conditions.
Cytotoxicity Test
BxPC-3 cells were treated with accutase and detached from the
plate at 37◦C for 15 min. The detached cells were collected using
centrifugation and diluted to 1 × 105 cells/mL. An aliquot of
the sample (0.34 mL) was added to each well of the 96-well
plate. The HIFU irradiation group was placed in the water bath
and HIFU irradiation was performed. During the experiment,
the temperature of the water bath was maintained at 25 ± 2◦C.
HIFU-irradiated samples were dispensed at 0.1 mL into a 96-
well microplate and cultured for the specified duration at 37◦C
and 5% CO2 in an incubator. After cell culture, 10 µL of CCK-8
was added and incubated for an additional 4 h at 37◦C. The cell
number was measured using a microplate reader (Infinite M1000
PRO, Tecan, Männedorf, Switzerland) at a wavelength of 438 nm.
Cell viability was calculated using untreated cells as a control.
Hydroxyl Radical Detection Assay
To detect hydroxyl radicals, fluorescence was measured using
HPF. HPF was added to the sample solution at a final
concentration of 0.025 mM. The sample solution was irradiated
with HIFU after dispersion into a 48-well microplate (1.3 mL).
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The sample was dispensed into a 96-well plate for fluorescence
intensity measurement. The fluorescence of the decomposed
substance (HPF to fluorescein, ex. 490 nm, em. 515 nm) was
measured in a microplate-reader (Infinite M1000 PRO). Three
samples were included in each group, and the average value and
standard deviation of the fluorescence changes were calculated.
Super Oxide Detection Assay
To measure superoxide anions, the WST-1 method was used
(Ukeda et al., 1999). WST-1 was added to DPBS at a final
concentration of 0.2 mM, and then NC-6300 or EPI was added
to the 48-well microplate (1.3 mL) and TP-HIFU irradiation was
performed (100 W/cm2, 0.5–3 min) at 25◦C. The absorbance
at a wavelength of 438 nm was measured using a UV-VIS-
near infrared spectrophotometer (V-670DS, JASCO, Tokyo,
Japan). Three samples were evaluated for each group, and the
average value and standard deviation of absorbance changes were
calculated before and after HIFU irradiation.
Flow Cytometer Analysis
The cellular accumulation of annexin V-FITC and PI was
monitored using flow cytometry to detect changes in the
membrane structure caused by ROS. HL-60 cells were cultured
in RPMI-1640 medium containing 10% fetal bovine serum
and penicillin-streptomycin, and diluted to 1 × 105 cells/mL,
and hydroxyl radicals or superoxide anions were generated
by the Fenton reaction or xanthine/xanthine oxidase reaction.
In the Fenton reaction, H2O2 solution and FeSO4 solution
were added to a final concentration of 0.005–0.02 mM. In
the xanthine/xanthine oxidase reaction, xanthine and xanthine
oxidase were added to final concentrations of 0.005–0.02 mM and
40 mU/mL, respectively. The reaction was carried out at 37◦C and
5% CO2 in an incubator. After incubation for 6 h, annexin-FITC
and PI were added according to the manufacturer’s instructions
and the luminescence of FITC and PI was monitored with a
flow cytometer (LSR Fortessa X-20, BD Biosciences, Franklin
Lakes, NJ, United States) and analyzed using FlowJo v10 software
(FlowJo LLC, Ashland, OR, United States).
Statistical analysis was carried out by using JMP software ver.
13.0.0 (SAS Institute, Cary, NC, United States).
RESULTS
We evaluated the effect of TP-HIFU irradiation and compared
the amounts of hydroxyl radicals generated by N-HIFU and
TP-HIFU. TP-HIFU generated more hydroxyl radicals even
with short-duration irradiation compared to N-HIFU. Hydroxyl
radical levels also increased as the HIFU intensity increased.
The cytoreductive effect of TP-HIFU was examined using
BxPC-3 cells. The cells were irradiated with TP-HIFU or
N-HIFU after detachment using accutase treatment. After 48 h
of incubation, the survival of adherent cells significantly differed
between the TP-HIFU and N-HIFU treatment groups.
Based on these results, TP-HIFU is a useful method for
generating cavitation and cell killing effects after short-duration
irradiation (Figure 2).
FIGURE 2 | (A) Hydroxyl radical measurement by HPF method. In the Fenton
reaction sample, H2O2 solution and FeSO4 solution were both added to HPF
solution to final concentration of 5, 10, and 20 µM, respectively. The
fluorescence intensity of the fluorescein released from HPF by hydroxyl
radicals was measured with a microplate reader (ex./em. = 490/515 nm).
HIFU irradiation groups were collected for five or more irradiation samples and
the results are presented as the mean ± standard deviation. ∗P < 0.05
non-parametric comparison for each pair by Wilcoxon test. (B) Cell viability
assay of BxPC-3 cell line. Suspension of detached BxPC-3 cells were
dispensed into a 96-well microplate for HIFU irradiation. Viable-cell counting
was carried out by CCK-8 method. Each group was collected for 20 or more
irradiation samples and the results are presented as the mean ± standard
deviation. ∗P < 0.05, ∗∗P < 0.01, non-parametric comparison for each pair
by Wilcoxon test.
To confirm the stability of EPI against TP-HIFU, the change
in the concentration of EPI upon TP-HIFU irradiation was
measured. EPI showed slight decrease in concentration by TP-
HIFU irradiation. However, EPI degradation was suppressed
when NC-6300 was irradiated.
Because hydroxyl radicals may be related to EPI degradation
upon HIFU irradiation, we examined the change in the
concentration of EPI by hydroxyl radical addition using the
Fenton reaction. The Fenton reaction is a source of hydroxyl
radicals produced by the mixing of iron ion and H2O2. The
EPI concentration was decreased by the generation of hydroxyl
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FIGURE 3 | (A) EPI degradation test by TP-HIFU irradiation. The sample
solution containing NC-6300 or EPI (0.1 mg/mL EPI concentration) was
irradiated 10 min by TP-HIFU in test tube made of glass. Residual amount of
EPI was calculated with non-irradiated sample set to 100%. The irradiation
groups were collected as three samples and presented as the
mean ± standard deviation. (B) EPI degradation test by Fenton reaction. The
sample solution containing NC-6300 or EPI (0.01 mM EPI concentration) was
treated with Fenton reaction in test tube. The residual amount of EPI was
measured by HPLC (n = 2–3) and presented as the mean ± standard
deviation. ∗P < 0.05, ∗∗P < 0.01, comparison for each pair by
Tukey–Kramer test.
radicals. However, NC-6300 was relatively stable after the
generation of hydroxyl radicals (Figure 3).
To investigate the potency of NC-6300 as a sonosensitizer,
we examined the detection of superoxide anion after HIFU
irradiation. Because we could not detect superoxide anion using
the electron spin resonance method, we used the spectroscopic
method as previously reported (Ukeda et al., 1999).
We measured the amount of superoxide anion generated
by TP-HIFU irradiation using a UV-VIS-near infrared
spectrophotometer. As a result, a concentration-dependent
increase in superoxide anion was observed when NC-6300
was irradiated by TP-HIFU. The TP-HIFU irradiation to
NC-6300 without WST-1, the superoxide indicator reagent,
showed no absorbance change. The amount of superoxide
reached a maximum level within 1 min of irradiation under this
experimental condition. Moreover, N-6300 showed a superior
ability to generate superoxide anion than did EPI. Addition of
superoxide dismutase suppressed the absorbance change after
TP-HIFU irradiation. The generated amount of superoxide
anion was estimated to be in the µM range compared with the
concentration of xanthine in the xanthine/xanthine oxidase
reaction (Figure 4).
To investigate the extracellular function of ROS at the
estimated level after TP-HIFU irradiation, we monitored the
apoptosis-related changes in the cells using flow cytometry.
HL-60 cells were incubated following addition of hydroxyl
radicals or superoxide anions using the Fenton reaction or
xanthine/xanthine oxidase reaction with or without NC-6300.
After 6 h of incubation, FITC- and PI-positive cells were
increased after adding both hydroxyl radicals and superoxide
anions. This change was accelerated by adding NC-6300 (5 µM),
which was not observed after adding NC-6300 alone (Figure 5).
DISCUSSION
To investigate the mechanism of the antitumor effects of NC-
6300 and TP-HIFU demonstrated previously (Maeda et al.,
2017), we evaluated the function of TP-HIFU. We found
that hydroxyl radical generation was promoted by TP-HIFU
irradiation (Figure 2A). We assume that the increase in cavitation
bubbles by TP-HIFU increases the production of hydroxyl
radicals after sonolysis (Misik and Riesz, 2000). It has been
reported that 8–15 µM of hydroxyl radicals were generated by
sonolysis under the irradiation conditions of 30 W, 1,650 kHz,
and 30 and 60 s (Nakamura et al., 2011). In contrast, the output
energy of TP-HIFU (Figure 2A) was one-third (10 W) that in
the aforementioned study and the same level of hydroxyl radicals
were obtained. The amount of hydroxyl radicals increased
with increasing irradiation intensity, even with short-duration
irradiation, suggesting that higher hydroxyl radical generation
occurs when the HIFU intensity is increased. These results
indicate that TP-HIFU irradiation produces more hydroxyl
radicals in a short duration and the amount of ROS will be
>20 µM under clinical conditions.
Additionally, higher cytoreductivity was observed with the
application of TR-HIFU irradiation (Figure 2B). Although the
triggering pulse in TP-HIFU is 2000 kw/cm2, the duration is very
short (0.02 ms/cycle, duty 0.2%). Thus, the total output energy
is nearly the same as that of N-HIFU which produces only a
heating wave. In the preliminary experiment, the temperature of
the microplate well was not increased beyond 35◦C throughout
irradiation and was within the non-thermal level. Despite these
conditions, the difference between TP-HIFU and N-HIFU was
clearly noticeable. To clarify the involvement of hydroxyl radicals
in cytotoxicity, we carried out an additional experiment with
1 W (10 W/cm2) of TP-HIFU irradiation and a hydroxyl radical
scavenger. We confirmed cytotoxicity at 1 W, and the effect
was suppressed after addition of 2 mM mannitol or histidine
(Supplementary Figure S1).
The results of EPI degradation by strong TP-HIFU irradiation
and similar results obtained from Fenton reaction suggest
that EPI degradation by TP-HIFU occurred mainly because
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FIGURE 4 | Measurement of the amount of superoxide anions by UV spectrophotometer. The sample solution containing 0.2 mM WST-1 and the indicated
concentration of NC-6300 or EPI (as EPI concentration) was irradiated by TP-HIFU. (A) TP-HIFU irradiation to NC-6300 in various concentration and at different
irradiation times. (B) Correlation with xanthine concentration in xanthine/xanthine oxidase reaction and absorbance change at 438 nm. (C) Comparison of the
generation of superoxide anion with NC-6300 and EPI. Superoxide dismutase (SOD) was added to confirm generation of the superoxide anion. The absorbance
change was measured at 438 nm and that of non-irradiated sample was subtracted. The irradiation groups were collected as three samples and presented as the
mean ± standard deviation. ∗∗P < 0.01, comparison for each pair by Tukey–Kramer test.
of hydroxyl radicals. In contrast, NC-6300 suppressed the
degradation of EPI (Figure 3). This may be because EPI
localization at the inner core and surrounding hydrophilic
moiety created by the PEG-polyamino acid polymer blocked
hydroxyl radical attack EPI (Figure 6). It is unclear whether
other drugs are protected in a similar manner, and further
experiments are necessary.
EPI was not released from NC-6300 even at high-power
irradiation (data not shown). The results indicate that the
hydrazone bond which conjugates the EPI and polymer was
not cleaved by TP-HIFU irradiation even at a high energy.
No significant change was observed in the particle size in the
nanoparticles after HIFU irradiation (data not shown). These
results indicate that cavitation generated under the current
conditions cannot cleave the conjugates.
In contrast, the generation of superoxide anions increased
following addition of NC-6300 (Figure 4). Although EPI itself
functioned as a sonosensitizer for generating superoxide anion,
NC-6300 generated more superoxide anion than EPI. We
assumed that EPI localized in the inner core at high concentration
acted promptly in the ROS generation process (Figure 6).
However, the fundamental mechanism underlying the generation
of superoxide radicals from epirubicin is unclear and warrants
further study (Figure 6).
Reactive oxygen species function is thought to be the key
component of SDT. In this study, we estimated the levels of
hydroxyl radicals and superoxide anions at the laboratory scale.
Hydroxyl radicals are thought to reach up to 20 µM and
superoxide anions are estimated to be present at up to one
tenth of the hydroxyl radicals. The results of flow cytometry
suggested that the cells were susceptible to ROS and that
apoptosis-like changes occurred at the outer membrane at 20µM
of hydroxyl radicals and super oxide anions. The hypothesis
that ROS might attack from the extracellular matrix is one of
the possible causes of this combination treatment. NC-6300 is
moved from blood vessel to tumor region by EPR effect and
may be first accumulated in the extracellular matrix (Chida
et al., 2018). We assume that some intervention of ROS could
occur from extracellular matrix to membrane (Supplementary
Figure S3). Further studies are necessary to determine the
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FIGURE 5 | Flow cytometry analysis of HL-60 cells. The cell suspension was dispensed into test tubes and hydroxyl radicals (HR) or superoxide anions (SA) were
added by Fenton reaction or xanthine/xanthine oxidase reaction. After 6-h incubation at 37◦C, the samples were measured by flow cytometry. (A) FITC and PI
intensity changes were monitored to confirm changes in the cell membrane upon extracellular addition of ROS and NC-6300. (B) Percentage of the number of FITC-
and PI-double-positive cells (Q2 region). Three samples were collected form each group and the results are presented as the mean ± standard deviation.
∗∗P < 0.01, comparison for each pair by Tukey–Kramer test.
following mechanism after the ROS have attacked from outside
of the cellular membrane.
Furthermore, intracellular ROS levels were not determined
in this study. Temporal increases in intracellular ROS levels
were observed after 30 min of ultrasound irradiation to metal-
porphyrin complexes (Giuntini et al., 2018), despite the short
(<1 s) lifetime of ROS. Combined use of folate-polyethylene-
glycol decorated gold nanoparticles and ultrasound irradiation
shows remarkable cytotoxicity and ROS production in folate
receptor overexpressing cells. However, the effect was suppressed
when the cell uptake of the particles was blocked by co-incubation
with excess free folate (Brazzale et al., 2016). It is also reported
that ROS generated by SDT is related to autophagy (Li et al.,
2017; Kou et al., 2017). These findings indicates the possibility of
a late-phase effect of ROS after TP-HIFU irradiation, warranting
further experiments.
In addition, we assume that more therapeutic effects are
expected in this therapy because we confirmed cooperative
HIFU-derived features (ablation, mechanical destruction, and
cavitation), an anticancer drug, and ROS within the dose
that is clinically safe. First, cell destruction by TP-HIFU was
immediately observed (Supplementary Figure S2, 24 h). Second,
the anticancer drug suppressed cell proliferation to inhibit
tumor growth. Finally, induced apoptosis further decreased
the cancer cell population (Supplementary Figure S2, 72 h).
One possible clinical benefit is that the anticancer drug is no
longer necessary for cell reduction because HIFU takes over
this function and reduces the dose of drug required from
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FIGURE 6 | Scheme of the characteristic function of NC-6300 in SDT. (A) Protective effect from hydroxyl radical. (B) Promoting effect of superoxide anion.
the levels used for cell killing to that for suppressing cell
“growth”. Thus, the safety margin for drug administration should
be reevaluated. Chemo-radio therapy is the most widely used
therapy. However, the mechanism of radiotherapy does not
provide an immediate effect for physical reduction (such as in
surgery and thermal coagulation).
One of the benefits of using drug delivery system carrier
conjugation with anticancer drugs is improved safety, which leads
to improved quality of life. However, additional non-clinical data
are required for each target organ to determine their suitability
for treatment with nano-micelles. In some cases, the drug alone
be the best treatment. TP-HIFU irradiation may enhance the
accumulation of micelles in cancer tissues, which requires further
analysis. Moreover, a diagnostic technology that can precisely
detect smaller target cancer colonies is required.
It has been reported that various types of cancer-associated
cells are localized in the tumor microenvironment (Junttila
and De Sauvage, 2013). It is thought that there is a specific
condition for each cancer-associated cell according to its
differentiation and localization. For example, metastatic cells
which are about to separate from the primary tumor mass and
migrate to another location might form small aggregates or
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single cells. In contrast, cancer-associated fibroblasts may be
in the form of clumps and attached to the tumor (Hwang
et al., 2008), suggesting that ablation is the most efficient
form of irradiation. To cover such various microenvironments,
combinations of different effects such as the treatment described
in this study are thought to be useful (Supplementary Figure S4).
In conclusion, drug-conjugated nano-micelles are more
desirable for SDT because of accelerated ROS production and
drug protection from ROS. Combinatorial treatment with NC-
6300 and TP-HIFU is a useful approach for minimally invasive
cancer therapy, combining the cooperative effects of HIFU-
derived features, anticancer activity of EPI, and increased ROS
generation to damage cancer cells.
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